BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/20/2019 5:32:10 AM | Browse: 822 | Download: 1172
 |
Received |
|
2018-10-16 01:49 |
|
Peer-Review Started |
|
2018-10-16 09:11 |
|
To Make the First Decision |
|
2018-12-05 06:17 |
|
Return for Revision |
|
2018-12-05 09:10 |
|
Revised |
|
2019-02-20 16:25 |
|
Second Decision |
|
2019-02-22 09:17 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-02-23 05:23 |
|
Articles in Press |
|
2019-02-23 05:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-03-07 20:00 |
|
Typeset the Manuscript |
|
2019-03-19 06:51 |
|
Publish the Manuscript Online |
|
2019-03-20 05:32 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ilias Gountas, Vana Sypsa, George Papatheodoridis, Kyriakos Souliotis, Kostas Athanasakis, Homie Razavi and Angelos Hatzakis |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Angelos Hatzakis, PhD, Doctor, Doctor, Senior Researcher, Senior Scientist, Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 22 Mikras Asias Str., Athens 11527, Greece. ahatzak@med.uoa.gr |
| Key Words |
Hepatitis C elimination; Cost effectiveness; Cost of elimination; Indirect costs; Projections; Mathematical modelling; Awareness and screening programs; World Health Organization targets |
| Core Tip |
Elimination of hepatitis C virus (commonly known as HCV) cannot be achieved in Greece without the implementation of large awareness and screening programs, as treatment coverage will be suboptimal. To achieve the elimination goals, 90000 patients need to be treated by 2030. The overall cumulative cost of elimination would range from 3.2-3.4 billion euros by 2030. The HCV elimination strategy in Greece is feasible and cost-saving despite the uncertainty of the future cost of the direct-acting antivirals. |
| Publish Date |
2019-03-20 05:32 |
| Citation |
Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Athanasakis K, Razavi H, Hatzakis A. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals. World J Gastroenterol 2019; 25(11): 1327-1340 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i11/1327.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i11.1327 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
